Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03877822
Other study ID # 190206/B/05
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date September 1, 2021

Study information

Verified date November 2021
Source University of Exeter
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The impact of two days bed rest versus two days of habitual activity on insulin sensitivity and cumulative muscle protein synthesis will be investigated in healthy young males


Description:

To study the mechanisms underlying inactivity-induced muscle atrophy, the impact of two days bed rest versus two days of habitual activity on insulin sensitivity and cumulative muscle protein synthesis will be investigated in healthy young males


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 1, 2021
Est. primary completion date September 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Male - Aged 18-40 Exclusion Criteria: - Smoker - Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) - Any diagnosed cardiovascular disease (e.g. deep vein thrombosis or hypertension) - Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate muscle protein metabolism). - A personal or family history of thrombosis, epilepsy, seizures or schizophrenia. - Any known disorders in muscle metabolism - Regular use of nutritional supplements (i.e. ingestion more than twice per week during the last month) - Metallic implants (including heart pacemaker, cochlear implants, medication pumps, surgical clips, plates or screws). - Allergy to lidocaine - Recent (within the last 6 months) or current musculoskeletal injury (e.g. leg fracture)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Habitual activity
Two days of habitual physical activity, under normal free-living conditions
Bed rest
Two days of bed rest, to induce whole-body physical inactivity

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Exeter

Outcome

Type Measure Description Time frame Safety issue
Primary Change in whole-body insulin sensitivity Change in whole-body insulin sensitivity via meal tolerance test During 2 days of habitual physical activity and 2 days of bed rest. Blood glucose and insulin are monitored for 2 hours following ingestion of a standardized meal
Secondary Change in cumulative muscle protein synthesis Cumulative muscle protein synthesis via deuterium oxide ingestion. The incorporation of deuterated alanine in muscle is expressed relative to body water enrichments, to obtain muscle protein synthesis in %/day During 2 days of habitual physical activity and 2 days of bed rest
Secondary Change in continuous glucose Change in continuous glucose via continuous glucose monitoring. Continuous glucose, during the 2 days of habitual activity and 2 days of bed rest
Secondary Change in muscle volume Change in muscle volume via MRI Immediately before and immediately after the 2-day bed rest period
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1